MedTrace Logo

Hepatic Fibrosis Non-invasive Methods Questionnaire

NCT02132351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 717

Last updated 2016-04-11

No results posted yet for this study

Summary

Due to the limitations and the invasive nature of liver biopsy, there has been extensive interest in developing non-invasive tests to measure liver fibrosis (1). These are alternatives to liver biopsy that can be used in clinical practice, with benefits in terms of cost, risk, and patient convenience (2). Clinically applicable non-invasive tests include radiological studies, transient elastography (TE), and serum markers. We aim at studying acceptability, reliability, applicability and practical aspects of invasive and noninvasive methods for assessment of hepatic fibrosis and cirrhosis among hepatologists.

Conditions

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Mohamed Alboraie, M.Sc · Al-Azhar University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02132351 on ClinicalTrials.gov